Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
September 22, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health...
Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health
May 31, 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company producing natural,...
Cybin, MindMed, and Field Trip Health Headline PSYC’s First CEO Round Table Event
February 14, 2022 08:30 ET
|
Global Trac Solutions, Inc.
LAKE OSWEGO,OR, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a media leader for the emerging medicinal psychedelics sector, and...
“The Science Behind Using Psychedelics To Treat Mental Health Disorders And Addiction Is Compelling”
June 16, 2021 07:30 ET
|
OTC Stock Review
OTCStockReview.com News Commentary ATLANTA, June 16, 2021 (GLOBE NEWSWIRE) -- Jim Cramer discussed psychedelics on his June 15, 2021 program and said, “The science behind using psychedelics to...
The Power of the Platform in Psychedelic Medicine
April 20, 2021 07:00 ET
|
OTC Stock Review
ATLANTA, April 20, 2021 (GLOBE NEWSWIRE) -- If you had a time machine and could go back to the first day of 2020, you would find that very few people were talking about psychedelics and their...